Capital for Cures AG is building the intelligence infrastructure for pharmaceutical royalty transactions.

Our platform gives royalty fund analysts, biotech BD teams, and university tech transfer offices the data edge they need — covering 5,000+ deals with royalty rates, licensing chains, and transaction histories, including hard-to-find private company data that no other source provides.

We also publish The Weekly Term Sheet via p05.org, the go-to weekly briefing on pharma and biotech deal flow, royalty financing, and life sciences transactions.Based in Zurich. 

Serving the global life sciences capital markets.

Capital for Cures AG

Org chart

Teams

Offices